Featured Article Repair Biotechnologies and Genevant Sciences to Collaborate to Develop mRNA-LNP Therapy with First-in-Class Potential to Turn Back Atherosclerosis Read more
Featured Article Repair Biotechnologies Announces Appointment of Noted Cardiologists to Scientific Advisory Board Read more
Featured Article Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models Read more
Repair Biotechnologies and Genevant Sciences to Collaborate to Develop mRNA-LNP Therapy with First-in-Class Potential to Turn Back Atherosclerosis
Repair Biotechnologies and Genevant Sciences to Collaborate to Develop mRNA-LNP Therapy with First-in-Class Potential to Turn Back Atherosclerosis Read more
Repair Biotechnologies Announces Appointment of Noted Cardiologists to Scientific Advisory Board Read more
Repair Biotechnologies Announces 48% Reversal of Atherosclerotic Plaque Lipids in a Preclinical Mouse Study Read more
